Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Michael Hopp

Clinical trials sponsored by Michael Hopp, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Immunotherapy combo shows promise against tough lung cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Immunotherapy combo shows promise against tough lung cancer

Disease control Ongoing

This phase 2 trial tests whether adding the immunotherapy drug durvalumab (Imfinzi) to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer without their cancer growing. About 105 participants will receive either the standard t…

Phase 2 • Sponsor: Michael Hopp • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC